{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T19:42:34Z","timestamp":1715974954512},"reference-count":47,"publisher":"The Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Functional ovarian hyperandrogenism, a variant of polycystic ovary syndrome, is often associated with hyperinsulinism and dyslipidemia. The mechanisms interlinking this triad are poorly understood; both hyperandrogenism and hyperinsulinism have been proposed as factors involved in the pathogenesis of the dyslipidemia. Precocious pubarche (PP) in girls is a risk factor for subsequent anovulation, ovarian and adrenal hyperandrogenism, hyperinsulinism and dyslipidemia.<\/jats:p>\n               <jats:p>Flutamide, a nonsteroidal antiandrogen, is known to be effective in reducing hirsutism in patients with ovarian hyperandrogenism. However, the effects of flutamide on the endocrine-metabolic correlates of hyperandrogenism are uncertain. We assessed the effects of low dose flutamide treatment (250 mg daily for 18 months) on hormonal and metabolic variables in 18 nonobese adolescent girls (age, 16.8 \u00b1 0.3 yr) with functional ovarian hyperandrogenism (diagnosis by GnRH agonist test) after PP.<\/jats:p>\n               <jats:p>Flutamide treatment was accompanied by a marked decrease in the hirsutism score, free androgen index, and testosterone, androstenedione, and dehydroepiandrosterone levels and by an increase in sex hormone-binding globulin concentrations. However, there were no substantial changes in the pattern of menstrual cycles, gonadotropin, estradiol, or dehydroepiandrosterone sulfate concentrations, and there was no detectable effect on the 17-hydroxyprogesterone response to GnRH agonist. Serum triglycerides, total cholesterol, and low-density lipoprotein cholesterol levels decreased markedly during flutamide therapy, whereas high-density lipoprotein cholesterol, fasting glycemia\/insulinemia, and the insulin response to a glucose load remained unchanged. Flutamide was well tolerated.<\/jats:p>\n               <jats:p>In conclusion, low dose flutamide treatment was found to be an effective and safe approach to reduce hirsutism and circulating androgen, low-density lipoprotein cholesterol, and triglyceride levels in girls with functional ovarian hyperandrogenism after PP. However, flutamide failed to increase high-density lipoprotein cholesterol levels or decrease hyperinsulinemia, i.e. to affect two major risk factors for subsequent cardiovascular disease.<\/jats:p>","DOI":"10.1210\/jcem.85.9.6814","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:06:07Z","timestamp":1389200767000},"page":"3251-3255","source":"Crossref","is-referenced-by-count":5,"title":["Treatment of Hirsutism, Hyperandrogenism, Oligomenorrhea, Dyslipidemia, and Hyperinsulinism in Nonobese, Adolescent Girls: Effect of Flutamide*"],"prefix":"10.1210","volume":"85","author":[{"given":"Lourdes","family":"Iba\u0301n\u0303ez","sequence":"first","affiliation":[{"name":"Endocrinology Unit, Hospital Sant Joan de De\u0301u, University of Barcelona (L.I.), Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neus","family":"Potau","sequence":"additional","affiliation":[{"name":"Hormonal Laboratory, Hospital Vall d\u2019Hebron, Autonomous University of Barcelona (N.P.), Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Victoria","family":"Marcos","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, Consorci Hospitalari de Terrassa (M.V.M.), Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"de Zegher","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Leuven (F.d.Z.), Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071613535118500_R1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/edrv-16-3-322","article-title":"Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.","volume":"16","author":"Ehrman","year":"1995","journal-title":"Endocr Rev"},{"key":"2020071613535118500_R2","article-title":"Ovarian and adrenal function in polycystic ovary syndrome. In: Dunaif A, ed","author":"Rosenfield","year":"1999"},{"key":"2020071613535118500_R3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2007-1016294","article-title":"Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome and its clinical implications.","volume":"15","year":"1997","journal-title":"Semin Reprod Endocrinol"},{"key":"2020071613535118500_R4","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.","volume":"18","year":"1997","journal-title":"Endocr Rev"},{"key":"2020071613535118500_R5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-2265.1996.674495.x","article-title":"Dyslipidemia is associated with insulin resistance in women with polycystic ovaries.","volume":"44","author":"Robinson","year":"1996","journal-title":"Clin Endocrinol"},{"key":"2020071613535118500_R6","first-page":"1147","article-title":"Impaired adipocyte lipolysis in non-obese women with the polycystic ovary syndrome: a possible link to insulin resistance?","volume":"82","author":"Ek","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613535118500_R7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0303-7207(86)90132-2","article-title":"Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues.","volume":"44","author":"Simard","year":"1986","journal-title":"Mol Cell Endocrinol"},{"key":"2020071613535118500_R8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0015-0282(16)57785-1","article-title":"Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behavior.","volume":"64","author":"Moghetti","year":"1995","journal-title":"Fertil Steril"},{"key":"2020071613535118500_R9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2265.1995.tb02922.x","article-title":"Clinical efficacy and safety of low-dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism.","volume":"43","author":"Dodin","year":"1995","journal-title":"Clin Endocrinol"},{"key":"2020071613535118500_R10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0015-0282(98)00486-5","article-title":"Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects.","volume":"71","author":"Fruzzetti","year":"1999","journal-title":"Fertil Steril"},{"key":"2020071613535118500_R11","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1210\/jcem.84.4.5591","article-title":"A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism.","volume":"84","author":"Venturoli","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613535118500_R12","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0015-0282(97)00266-5","article-title":"A comparison between two doses of flutamide (250 mg\/d and 500 mg\/d) in the treatment of hirsutism.","volume":"68","author":"Mu\u0308derris","year":"1997","journal-title":"Fertil Steril"},{"key":"2020071613535118500_R13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1210\/jcem.83.1.4500","article-title":"Hormonal effects of flutamide in young women with polycystic ovary syndrome.","volume":"83","author":"Leo,","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613535118500_R14","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1210\/jcem.83.8.5041","article-title":"The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome.","volume":"83","author":"Diamanti-Kandarakis","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613535118500_R15","first-page":"952","article-title":"The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action.","volume":"81","author":"Moghetti","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613535118500_R16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1365-2265.1998.00483.x","article-title":"Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin releasing factor (CRF).","volume":"49","author":"Leo","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613535118500_R17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/09513599509160450","article-title":"Prolonged treatment of hirsutism with flutamide alone in patients affected by polycystic ovary syndrome.","volume":"9","author":"Pucci","year":"1995","journal-title":"Gynecol Endocrinol"},{"key":"2020071613535118500_R18","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0026-0495(95)90062-4","article-title":"Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome.","volume":"44","author":"Diamanti-Kandarakis","year":"1995","journal-title":"Metabolism"},{"key":"2020071613535118500_R19","first-page":"448","volume":"72","author":"Paoletti","year":"1999"},{"key":"2020071613535118500_R20","article-title":"Androgens in adrenarche and pubarche. In: Azziz R, Nestler JE, Dewailly D, eds","author":"Iba\u0301n\u0303ez","year":"1997"},{"key":"2020071613535118500_R21","first-page":"2691","article-title":"Anovulation after precocious pubarche: early markers and time course in adolescence.","volume":"84","author":"Iba\u0301n\u0303ez","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613535118500_R22","first-page":"1599","article-title":"Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased incidence of functional ovarian hyperandrogenism.","volume":"76","author":"Iba\u0301n\u0303ez","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613535118500_R23","first-page":"2283","article-title":"Hyperinsulinemia and decreased insulin-like growth factor binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche.","volume":"82","author":"Iba\u0301n\u0303ez","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613535118500_R24","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s001250051030","article-title":"Hyperinsulinemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche.","volume":"41","author":"Iba\u0301n\u0303ez","year":"1998","journal-title":"Diabetologia"},{"key":"2020071613535118500_R25"},{"key":"2020071613535118500_R26","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1210\/jcem.83.10.5205","article-title":"Precocious pubarche, hyperinsulinism and ovarian hyperandrogenism in girls: relation to reduced fetal growth.","volume":"83","author":"Iba\u0301n\u0303ez","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613535118500_R27","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1203\/00006450-199909000-00012","article-title":"Precocious pubarche, dyslipidemia, and low IGF binding protein-1 in girls: relation to reduced prenatal growth.","volume":"46","author":"Iba\u0301n\u0303ez","year":"1999","journal-title":"Pediatr Res"},{"key":"2020071613535118500_R28","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women.","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613535118500_R29","first-page":"1778","volume":"79","author":"Iba\u0301n\u0303ez","year":"1994"},{"key":"2020071613535118500_R30"},{"key":"2020071613535118500_R31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archpedi.1991.02160030027015","article-title":"Standardized percentile curves of body mass index for children and adolescents.","volume":"145","author":"Hammer","year":"1991","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2020071613535118500_R32","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jcem-57-2-320","article-title":"Genotyping steroid 21-hydroxylase deficiency: hormonal reference data.","volume":"56","author":"New","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613535118500_R33","first-page":"3961","article-title":"Studies of 3\u03b2-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated \u03945-steroid levels.","volume":"81","author":"Sakkal-Alkaddour","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613535118500_R34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1530\/eje.0.1410027","article-title":"Sexual dimorphism in the maturation of the pituitary-gonadal axis, assessed by gonadotropin-releasing hormone agonist challenge.","volume":"141","author":"Potau","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"2020071613535118500_R35","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.","volume":"20","year":"1997","journal-title":"Diabetes Care"},{"key":"2020071613535118500_R36","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0015-0282(16)57174-X","article-title":"Treatment of hirsutism with flutamide and a low-dosage oral contraceptive in polycystic ovary syndrome.","volume":"62","author":"Ciotta","year":"1994","journal-title":"Fertil Steril"},{"key":"2020071613535118500_R37","doi-asserted-by":"crossref","first-page":"860","DOI":"10.7326\/0003-4819-118-11-199306010-00006","article-title":"Fatal and nonfatal hepatotoxicity associated with flutamide.","volume":"118","author":"Wysowski","year":"1993","journal-title":"Ann Intern Med"},{"key":"2020071613535118500_R38","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(99)00564-4","article-title":"Fulminant liver failure associated with flutamide therapy for hirsutism.","volume":"353","author":"Andrade","year":"1999","journal-title":"Lancet"},{"key":"2020071613535118500_R39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0022-4731(87)90122-1","article-title":"Inhibition of rat testicular 17\u03b1-hydroxylase and 17,20-lyase activities by antiandrogens (flutamide, hydroxyflutamide, RU23908, cyproterone acetate) in vitro.","volume":"28","author":"Ayub","year":"1987","journal-title":"J Steroid Biochem"},{"key":"2020071613535118500_R40","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1210\/jcem.81.3.8772576","article-title":"Insulin sensitivity, lipids and body composition in childhood: is \u201csyndrome X\u201d present?.","volume":"81","author":"Arslanian","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613535118500_R41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.ATV.17.1.107","article-title":"Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality: a 21-year follow-up of 8000 men.","volume":"17","author":"Goldbourt","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2020071613535118500_R42","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM199908053410604","article-title":"Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol.","volume":"341","author":"Rubins","year":"1999","journal-title":"N Engl J Med"},{"key":"2020071613535118500_R43","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1056\/NEJM199604113341504","article-title":"Hyperinsulinemia as an independent risk factor for ischemic heart disease.","volume":"334","author":"Despre\u0301s","year":"1996","journal-title":"N Engl J Med"},{"key":"2020071613535118500_R44","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/BF00403180","article-title":"Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome.","volume":"34","author":"Ferrannini","year":"1991","journal-title":"Diabetologia"},{"key":"2020071613535118500_R45","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1056\/NEJM199312303292703","article-title":"Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus.","volume":"329","author":"Lillioja","year":"1993","journal-title":"N Engl J Med"},{"key":"2020071613535118500_R46","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613535118500_R47","first-page":"1648","article-title":"Exogenous androgens influence body composition and body fat distribution in obese postmenopausal women\u2013a clinical research center study.","volume":"81","author":"Lovejoy","year":"1996","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/85\/9\/3251\/9061257\/jcem3251.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/85\/9\/3251\/9061257\/jcem3251.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:54:31Z","timestamp":1594947271000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/85\/9\/3251\/2660593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9,1]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2000,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.85.9.6814","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9,1]]}}}